We are live on ! Find out more
QF

QVT Financial Portfolio holdings

AUM $1.37B
1-Year Est. Return 148.1%
This Fund
S&P 500
This Quarter Est. Return
-5.56%
1 Year Est. Return
+148.1%
3 Year Est. Return
+280.64%
5 Year Est. Return
+413.55%
10 Year Est. Return
+2,213.36%
AUM
$3.29B
AUM Growth
+$640M
Cap. Flow
+$220M
Cap. Flow %
6.67%
Top 10 Hldgs %
73.26%
Holding
93
New
21
Increased
13
Reduced
25
Closed
8

Top Buys

Rank Stock Value
1
MYOV
Myovant Sciences Ltd.
MYOV
+$431M
2
KMX icon
CarMax
KMX
+$18.4M
3
MMYT icon
MakeMyTrip
MMYT
+$10.6M
4
IBB icon
iShares Biotechnology ETF
IBB
+$10.5M
5
HUNTU
Hunter Maritime Acquisition Corp. Unit
HUNTU
+$10M

Top Sells

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$71M
2
THC icon
Tenet Healthcare
THC
+$15.3M
3
XLNX
Xilinx Inc
XLNX
+$12.9M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$11.4M
5
BRFS
BRF SA
BRFS
+$10.4M

Sector Composition

Rank Sector Weight
1 Healthcare 48.57%
2 Consumer Discretionary 2.87%
3 Communication Services 2.44%
4 Technology 2.2%
5 Financials 1.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XRT icon
51
State Street SPDR S&P Retail ETF
XRT
$365M
$5.21M 0.16%
+118,270
New +$5.26M
ONC
52
BeOne Medicines Ltd
ONC
$33.8B
$5.16M 0.16%
170,000
– –
ATHM icon
53
Autohome
ATHM
$2.43B
$5.1M 0.16%
201,900
+120,500
+148% +$3.11M
ATVI
54
DELISTED
Activision Blizzard
ATVI
$4.83M 0.15%
+133,900
New +$5.35M
RGNX icon
55
Regenxbio
RGNX
$623M
$4.64M 0.14%
250,104
-120,839
-33% -$2.31M
BLCM
56
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$4.6M 0.14%
33,792
-5,092
-13% -$904K
DHT icon
57
DHT Holdings
DHT
$2.97B
$4.44M 0.13%
+1,071,966
New +$4.25M
FIT
58
DELISTED
Fitbit, Inc. Class A common stock
FIT
$4.19M 0.13%
572,202
-7,300
-1% -$74.8K
ARWR icon
59
Arrowhead Research
ARWR
$12.1B
$3.96M 0.12%
2,556,256
– –
BIIB icon
60
Biogen
BIIB
$29.9B
$3.33M 0.1%
+11,760
New +$3.49M
HMLP
61
DELISTED
HOEGH LNG PARTNERS LP
HMLP
$3.33M 0.1%
+175,000
New +$3.2M
ADAP
62
DELISTED
Adaptimmune Therapeutics
ADAP
$2.66M 0.08%
657,258
-64,975
-9% -$312K
NAT icon
63
Nordic American Tanker
NAT
$1.37B
$2.39M 0.07%
286,511
-198,458
-41% -$1.76M
PTN
64
Palatin Technologies
PTN
$13.7M
$2.25M 0.07%
5,092
+1,861
+58% +$1.3M
OCRX
65
DELISTED
Ocera Therapeutics, Inc.
OCRX
$1.9M 0.06%
906,286
-25,800
-3% -$60.2K
TCON
66
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$1.71M 0.05%
1,907
+236
+14% +$270K
AKTX
67
Akari Therapeutics
AKTX
$15.2M
$1.45M 0.04%
323
-7
-2% -$45.2K
TSLA icon
68
PUT
Tesla
TSLA
$1.24T
$1.05M 0.03%
+669,900
New +$8.8M
SRLP
69
DELISTED
SPRAGUE RESOURCES LP
SRLP
$785K 0.02%
30,909
-9,070
-23% -$225K
INSW icon
70
International Seaways
INSW
$4.57B
$257K 0.01%
+18,309
New +$246K
BRFS
71
DELISTED
BRF SA
BRFS
– –
-607,112
Closed -$10.4M
FRO icon
72
Frontline
FRO
$8.75B
– –
-408,341
Closed -$2.93M
THC icon
73
Tenet Healthcare
THC
$20.1B
– –
-676,765
Closed -$15.3M
XLNX
74
DELISTED
Xilinx Inc
XLNX
– –
-236,855
Closed -$12.9M
GNMX
75
DELISTED
Aevi Genomic Medicine Inc
GNMX
– –
-123,500
Closed -$688K
1 2
3
4

Similar funds

KRS
Kentucky Retirement Systems Frankfort, Kentucky $1.37B AUM 33.36% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
DC
Dendur Capital New York $1.36B AUM 38.43% 1-Year Est. Return
FC
FORA Capital Miami, Florida $1.36B AUM 56.1% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.37B AUM 20.67% 1-Year Est. Return

QVT Financial's Q4 2016 Portfolio in Review

As of Q4 2016, QVT Financial held 93 positions worth $3.29B, up 24% from $2.65B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

QVT Financial deployed $220M of net new capital in Q4 2016, opening 21 new positions and adding to 13 existing holdings. Its largest new stake was Myovant Sciences Ltd.: 37,231,342 shares worth $463M.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 51% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Goldman Sachs, an estimated $71M trimmed.

  • QVT Financial's largest Q4 2016 buy was Myovant Sciences Ltd.: 37,231,342 shares worth $463M.
  • QVT Financial added most to MakeMyTrip in Q4 2016, an estimated $10.6M increase.
  • QVT Financial's biggest Q4 2016 reduction was Goldman Sachs, cutting an estimated $71M.
  • QVT Financial fully exited Tenet Healthcare in Q4 2016, selling an estimated $15.3M.
  • QVT Financial's ten largest holdings make up 73% of its $3.29B portfolio in Q4 2016.
  • QVT Financial opened 21 new positions and closed 8 in Q4 2016.
  • QVT Financial's portfolio value rose 24% quarter-over-quarter to $3.29B.

Based on QVT Financial's 13F filing for Q4 2016, filed 14 Feb 2017.